Sweetness in the Blood: Race, Risk, and Type 2 Diabetes

Author:   James Doucet-Battle
Publisher:   University of Minnesota Press
ISBN:  

9781517908485


Pages:   240
Publication Date:   16 March 2021
Format:   Hardback
Availability:   Temporarily unavailable   Availability explained
The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you.

Our Price $180.00 Quantity:  
Add to Cart

Share |

Sweetness in the Blood: Race, Risk, and Type 2 Diabetes


Add your own review!

Overview

Full Product Details

Author:   James Doucet-Battle
Publisher:   University of Minnesota Press
Imprint:   University of Minnesota Press
Dimensions:   Width: 14.00cm , Height: 2.50cm , Length: 21.60cm
ISBN:  

9781517908485


ISBN 10:   1517908485
Pages:   240
Publication Date:   16 March 2021
Audience:   General/trade ,  Professional and scholarly ,  General ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Temporarily unavailable   Availability explained
The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you.

Table of Contents

Reviews

James Doucet-Battle has given us a brilliant book that uncovers the networks that support the pharmacapitalism of Type 2 diabetes. In this important study, we see the impact of economizing risk through biomarketing. Sweetness in the Blood is a must-read because it underscores the sacrificial labor of Black people as they become the targets of risk assessments for Type 2 diabetes and role that the technology plays in constructing 'racial risk.' -Dana-Ain Davis, author of Reproductive Injustice: Racism, Pregnancy, and Premature Birth Sweetness in the Blood is an indictment, not only of the global sugar industry, but of medical and biotech industries that insist on using biological race as a lens to explain and predict health disparities. Traversing breathtaking terrain, from sugar plantations to pharmaceutical board rooms, this is a must-read for everyone who wants to understand how social inequity gets under the skin and for all those committed to health justice. -Ruha Benjamin, author of Race After Technology*


"""James Doucet-Battle has given us a brilliant book that uncovers the networks that support the pharmacapitalism of Type 2 diabetes. In this important study, we see the impact of economizing risk through biomarketing. Sweetness in the Blood is a must-read because it underscores the sacrificial labor of Black people as they become the targets of risk assessments for Type 2 diabetes and role that the technology plays in constructing ‘racial risk.’""—Dána-Ain Davis, author of Reproductive Injustice: Racism, Pregnancy, and Premature Birth ""Sweetness in the Blood is an indictment, not only of the global sugar industry, but of medical and biotech industries that insist on using biological race as a lens to explain and predict health disparities. Traversing breathtaking terrain, from sugar plantations to pharmaceutical board rooms, this is a must-read for everyone who wants to understand how social inequity gets under the skin and for all those committed to health justice.""—Ruha Benjamin, author of Race After Technology ""Sweetness in the Blood adds nuance to our understanding of race and chronic disease prevention management.""—Ethnic and Racial Studies ""In Sweetness in the Blood: Race, Risk, and Type 2 Diabetes, James Doucet-Battle offers a sweeping indictment of ways in which racial essentialism infiltrates the science and industry surrounding modern diabetes.""—Social Forces ""In this important contribution to deconstructing the intersections of race, capital, and disease, Doucet-Battle employs an ethnographic approach to explore the racialization of a disease, showing how the combined enterprises of pharma and medicine have constructed being African American as a risk. ""—CHOICE ""Doucet-Battle successfully presses his readers to question a handful of taken-for-granted concepts (i.e., race, risk, and diabetes). In that respect, Sweetness in the Blood is a wonderful example of the sociological craft. ""—American Journal of Sociology"


James Doucet-Battle has given us a brilliant book that uncovers the networks that support the pharmacapitalism of Type 2 diabetes. In this important study, we see the impact of economizing risk through biomarketing. Sweetness in the Blood is a must-read because it underscores the sacrificial labor of Black people as they become the targets of risk assessments for Type 2 diabetes and role that the technology plays in constructing 'racial risk.' --Dana-Ain Davis, author of Reproductive Injustice: Racism, Pregnancy, and Premature Birth Sweetness in the Blood is an indictment, not only of the global sugar industry, but of medical and biotech industries that insist on using biological race as a lens to explain and predict health disparities. Traversing breathtaking terrain, from sugar plantations to pharmaceutical board rooms, this is a must-read for everyone who wants to understand how social inequity gets under the skin and for all those committed to health justice. --Ruha Benjamin, author of Race After Technology*


Author Information

James Doucet-Battle is assistant professor of sociology at the University of California, Santa Cruz.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List